Skip to main content

Table 3 Blood analysis of participants

From: Study of clinical traits and systemic immune inflammation index assessments in patients with endogenous endophthalmitis over the last ten years

(103/uL)

Control / All Endophthalmitis(n = 64/22)

P

Control / Group A(n = 64/13)

P

Group A / Group B(n = 9/13)

P

Neutrophil

3.09(2.06,3.91)/6.74(3.85, 8.66)

 < 0.001

3.09(2.06,3.91)/ 7.84(6.21, 11.04)

 < 0.001

4(2.81,6.57)/ 7.84(6.21, 11.04)

0.07

Lymphocyte

1.82(1.42,2.35)/ 1.81(1.49, 2.44)

0.92

1.82(1.42,2.35)/ 1.8(1.57, 2.36)

-

1.9(1.27, 2.49) / 1.8(1.57, 2.36)

-

Monocyte

0.29(0.25,0.38)/ 0.48(0.39, 0.56)

 < 0.001

0.29(0.25,0.38)/ 0.5(0.39, 0.57)

 < 0.001

0.4(0.33, 0.54) / 0.5(0.39, 0.57)

0.90

PLT

222.5(182.25, 264.25)/ 307(233.75, 412)

 < 0.00

222.5(182.25, 264.25)/ 300(232.5, 442)

0.008

314(253, 381.5) / 300(232.5, 442)

1

SII

385.19(258.65, 569.27)/ 1198.82(549.08, 2018.82)

 < 0.001

385.19(258.65, 569.27)/ 1687.16(863.57, 2636.62)

 < 0.001

790.38(324.18, 1801.32) / 1687.16(863.57, 2636.62)

0.28

NLR

1.89(1.25, 2.58)/ 3.93(1.85, 6.33)

 < 0.001

1.89(1.25, 2.58)/ 5.05(3.06, 7.80)

 < 0.001

1.92(1.09, 5.25) / 5.05(3.06, 7.80)

0.09

PLR

115.39(95.77, 149.11)/ 178.66(116.18, 266.90)

0.004

115.39(95.77, 149.11)/ 180.52(101.32, 274.18)

0.07

165.26(115.85, 279.14) / 180.52(101.32, 274.18)

1

MLR

0.16(0.12,0.21)/ 0.29(0.17, 0.36)

 < 0.001

0.16(0.12,0.21)/ 0.31(0.20, 0.37)

0.001

0.18(0.15, 0.39) / 0.31(0.20, 0.37)

0.88

Red Cell Distribution Width (%)

12.6(12.13, 13)/ 12.85(12,13.83)

0.47

12.6(12.13, 13)/ 13(12.4, 13.95)

-

12.1(12, 15.3)/ 13(12.4, 13.95)

-

  1. “-”stands for nonparametric test meaningless. The value is represented by M (P25, P75)